Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines

Control of the worldwide AIDS pandemic may require not only preventive but also therapeutic immunization strategies. To meet this challenge, the next generation of human immunodeficiency virus type 1 (HIV-1) vaccines must stimulate broad and durable cellular immune responses to multiple HIV antigens...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Virol
Päätekijät:	zur Megede, Jan, Otten, Gillis R., Doe, Barbara, Liu, Hong, Leung, Louisa, Ulmer, Jeffrey B., Donnelly, John J., Barnett, Susan W.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2003
Aiheet:	Vaccines and Antiviral Agents
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154993/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12743276/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.11.6197-6207.2003
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!